SCOPUS 정보 검색 플랫폼

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 7, 2011, Pages 2038-2039

Management of recurrent/persistent papillary thyroid carcinoma: Efficacy of the surgical option

(1) Schuff, Kathryn G a

a OREGON HEALTH AND SCIENCE UNIVERSITY (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN; THYROGLOBULIN;

CANCER RECURRENCE; CANCER REGRESSION; CERVICAL LYMPH NODE; EDITORIAL; HUMAN; HYPOPARATHYROIDISM; LYMPH NODE DISSECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT LARYNGEAL NERVE PALSY; RISK BENEFIT ANALYSIS; SURGICAL RISK; THYROID PAPILLARY CARCINOMA;

CARCINOMA, PAPILLARY; HUMANS; NEOPLASM RECURRENCE, LOCAL; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 79960095948 PISSN: 0021972X EISSN: 19457197 Source Type: Journal
DOI: 10.1210/jc.2011-1663 Document Type: Editorial

Times cited : (17)

References (14)

1
- 84875953914
- accessed May 27, 2011
- SEER cancer statistics. http://seer.cancer.gov/statfacts/html/thyro.html, accessed May 27, 2011
- SEER Cancer Statistics

2
- 17744412728
- Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996
- U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study
- Hundahl SA, Cady B, Cunningham MP, Mazzaferri E, McKee RF, Rosai J, Shah JP, Fremgen AM, Stewart AK, Hölzer S 2000 Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer 89:202-217
- (2000) Cancer , vol.89 , pp. 202-217
- Hundahl, S.A.¹ Cady, B.² Cunningham, M.P.³ Mazzaferri, E.⁴ McKee, R.F.⁵ Rosai, J.⁶ Shah, J.P.⁷ Fremgen, A.M.⁸ Stewart, A.K.⁹ Hölzer, S.¹⁰

3
- 0028302371
- 131)
- Coburn M, Teates D, Wanebo HJ 1994 Recurrent thyroid cancer: role of surgery versus radioactive iodine. Ann Surg 219:587-595 (Pubitemid 24182632)
- (1994) Annals of Surgery , vol.219 , Issue.6 , pp. 587-595
- Cobum, M.¹ Teates, D.² Wanebo, H.J.³ Byers, R.M.⁴ Thomas Jr., C.G.⁵ Irvin III, G.L.⁶

4
- 70449370231
- Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer
- Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
- (2009) Thyroid , vol.19 , pp. 1167-1214
- Cooper, D.S.¹ Doherty, G.M.² Haugen, B.R.³ Hauger, B.R.⁴ Kloos, R.T.⁵ Lee, S.L.⁶ Mandel, S.J.⁷ Mazzaferri, E.L.⁸ McIver, B.⁹ Pacini, F.¹⁰ Schlumberger, M.¹¹ Sherman, S.I.¹² Steward, D.L.¹³ Tuttle, R.M.¹⁴

5
- 79960087723
- The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation
- Yim JH, Kim WB, Kim EY, Kim WG, Kim TY, Ryu JS, Gong G, Hong SJ, Shong YK 2011 The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab 96:2049-2056
- (2011) J Clin Endocrinol Metab , vol.96 , pp. 2049-2056
- Yim, J.H.¹ Kim, W.B.² Kim, E.Y.³ Kim, W.G.⁴ Kim, T.Y.⁵ Ryu, J.S.⁶ Gong, G.⁷ Hong, S.J.⁸ Shong, Y.K.⁹

6
- 77952764723
- Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer
- Al-Saif O, Farrar WB, Bloomston M, Porter K, Ringel MD, Kloos RT 2010 Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab 95:2187-2194
- (2010) J Clin Endocrinol Metab , vol.95 , pp. 2187-2194
- Al-Saif, O.¹ Farrar, W.B.² Bloomston, M.³ Porter, K.⁴ Ringel, M.D.⁵ Kloos, R.T.⁶

7
- 43049097521
- Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer
- DOI 10.1097/MLG.0b013e318162cae9
- Schuff KG, Weber SM, Givi B, Samuels MH, Andersen PE, Cohen JI 2008 Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. Laryngoscope 118:768-775 (Pubitemid 351631273)
- (2008) Laryngoscope , vol.118 , Issue.5 , pp. 768-775
- Schuff, K.G.¹ Weber, S.M.² Givi, B.³ Samuels, M.H.⁴ Andersen, P.E.⁵ Cohen, J.I.⁶

8
- 68549107977
- Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma
- Clayman GL, Shellenberger TD, Ginsberg LE, Edeiken BS, El-Naggar AK, Sellin RV, Waguespack SG, Roberts DB, Mishra A, Sherman SI 2009 Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma. Head Neck 31:1152-1163
- (2009) Head Neck , vol.31 , pp. 1152-1163
- Clayman, G.L.¹ Shellenberger, T.D.² Ginsberg, L.E.³ Edeiken, B.S.⁴ El-Naggar, A.K.⁵ Sellin, R.V.⁶ Waguespack, S.G.⁷ Roberts, D.B.⁸ Mishra, A.⁹ Sherman, S.I.¹⁰

9
- 3142717545
- Management and outcome of recurrent well-differentiated thyroid carcinoma
- DOI 10.1001/archotol.130.7.819
- Palme CE, Waseem Z, Raza SN, Eski S, Walfish P, Freeman JL 2004 Management and outcome of recurrent well-differentiated thyroid carcinoma. Arch Otolaryngol Head Neck Surg 130:819-824 (Pubitemid 38915967)
- (2004) Archives of Otolaryngology - Head and Neck Surgery , vol.130 , Issue.7 , pp. 819-824
- Palme, C.E.¹ Waseem, Z.² Raza, S.N.³ Eski, S.⁴ Walfish, P.⁵ Freeman, J.L.⁶

10
- 21244441496
- Life expectancy in differentiated thyroid cancer: A novel approach to survival analysis
- DOI 10.1677/erc.1.00892
- Links TP, van Tol KM, Jager PL, Plukker JT, Piers DA, Boezen HM, Dullaart RP, de Vries EG, Sluiter WJ 2005 Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis. Endocr Relat Cancer 12:273-280 (Pubitemid 40896446)
- (2005) Endocrine-Related Cancer , vol.12 , Issue.2 , pp. 273-280
- Links, T.P.¹ Van Tol, K.M.² Jager, P.L.³ Plukker, J.T.M.⁴ Piers, D.A.⁵ Boezen, H.M.⁶ Dullaart, R.P.F.⁷ De Vries, E.G.E.⁸ Sluiter, W.J.⁹

11
- 0345303967
- Second primary malignancies in thyroid cancer patients
- DOI 10.1038/sj.bjc.6601319
- Rubino C, de Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE, Dondon MG, Abbas MT, Langlois C, Schlumberger M 2003 Second primary malignancies in thyroid cancer patients. Br J Cancer 89:1638-1644 (Pubitemid 37464133)
- (2003) British Journal of Cancer , vol.89 , Issue.9 , pp. 1638-1644
- Rubino, C.¹ De Vathaire, F.² Dottorini, M.E.³ Hall, P.⁴ Schvartz, C.⁵ Couette, J.E.⁶ Dondon, M.G.⁷ Abbas, M.T.⁸ Langlois, C.⁹ Schlumberger, M.¹⁰

12
- 39049152497
- The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer
- DOI 10.1210/jc.2007-1154
- Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD 2008 The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab 93:504-515 (Pubitemid 351240823)
- (2008) Journal of Clinical Endocrinology and Metabolism , vol.93 , Issue.2 , pp. 504-515
- Brown, A.P.¹ Chen, J.² Hitchcock, Y.J.³ Szabo, A.⁴ Shrieve, D.C.⁵ Tward, J.D.⁶

13
- 33744927671
- Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers
- DOI 10.1016/j.canlet.2005.06.015, PII S0304383505005628
- Chuang SC, Hashibe M, Yu GP, Le AD, Cao W, Hurwitz EL, Rao JY, Neugut AI, Zhang ZF 2006 Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers. Cancer Lett 238: 42-52 (Pubitemid 43851143)
- (2006) Cancer Letters , vol.238 , Issue.1 , pp. 42-52
- Chuang, S.-C.¹ Hashibe, M.² Yu, G.-P.³ Le, A.D.⁴ Cao, W.⁵ Hurwitz, E.L.⁶ Rao, J.-Y.⁷ Neugut, A.I.⁸ Zhang, Z.-F.⁹

14
- 67650403379
- Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: A systematic review and meta-analysis
- Sawka AM, Thabane L, Parlea L, Ibrahim-Zada I, Tsang RW, Brierley JD, Straus S, Ezzat S, Goldstein DP 2009 Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid 19:451-457
- (2009) Thyroid , vol.19 , pp. 451-457
- Sawka, A.M.¹ Thabane, L.² Parlea, L.³ Ibrahim-Zada, I.⁴ Tsang, R.W.⁵ Brierley, J.D.⁶ Straus, S.⁷ Ezzat, S.⁸ Goldstein, D.P.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.